Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$166.91 USD
-2.73 (-1.61%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $166.81 -0.10 (-0.06%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CRL 166.91 -2.73(-1.61%)
Will CRL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRL
Analysts Estimate AMN Healthcare Services (AMN) to Report a Decline in Earnings: What to Look Out for
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Charles River Q2 Earnings Preview: What's in Store for the Stock?
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
Is it Prudent to Retain Charles River Stock in Your Portfolio Now?
Other News for CRL
CRL Crosses Below Key Moving Average Level
Charles River (CRL) Explores New Partnership for Funding Opportunities
Charles River, BioTech Social to pursue crowdfunding partnership
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership | CRL Stock News
ClearBridge Growth Fund Q2 2025 Commentary